Fluocinonide Patent Expiration

Fluocinonide is Used for relieving inflammation and itching in dermatological conditions amenable to corticosteroid treatment in patients 12 years and older. It was first introduced by Alvogen Inc in its drug Fluocinonide on Approved Prior to Jan 1, 1982. Other drugs containing Fluocinonide are Lidex, Lidex-E, Vanos. 24 different companies have introduced drugs containing Fluocinonide.


Fluocinonide Patents

Given below is the list of patents protecting Fluocinonide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Vanos US8232264 Compositions and methods for enhancing corticosteroid delivery Mar 09, 2023

(Expired)

Bausch
Vanos US7220424 Compositions and methods for enhancing corticosteroid delivery Jan 07, 2023

(Expired)

Bausch
Vanos US7794738 Compositions and methods for enhancing corticosteroid delivery Sep 11, 2022

(Expired)

Bausch
Vanos US6765001 Compositions and methods for enhancing corticosteroid delivery Dec 21, 2021

(Expired)

Bausch



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Fluocinonide's patents.

Given below is the list recent legal activities going on the following patents of Fluocinonide.

Activity Date Patent Number
Patent litigations
Maintenance Fee Reminder Mailed 18 Mar, 2024 US8232264(Litigated)
Expire Patent 17 Oct, 2022 US7794738(Litigated)
Maintenance Fee Reminder Mailed 02 May, 2022 US7794738(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 02 Jan, 2020 US8232264(Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 30 Oct, 2018 US7220424(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 21 Feb, 2018 US7794738(Litigated)
Patent Issue Date Used in PTA Calculation 31 Jul, 2012 US8232264(Litigated)
Recordation of Patent Grant Mailed 31 Jul, 2012 US8232264(Litigated)
Email Notification 12 Jul, 2012 US8232264(Litigated)
Issue Notification Mailed 11 Jul, 2012 US8232264(Litigated)


Fluocinonide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Fluocinonide Generic API Manufacturers

Several generic applications have been filed for Fluocinonide. The first generic version for Fluocinonide was by Taro Pharmaceuticals Inc and was approved on Jun 10, 1987. And the latest generic version is by Quagen Pharmaceuticals Llc and was approved on Feb 26, 2025.

Given below is the list of companies who have filed for Fluocinonide generic, along with the locations of their manufacturing plants worldwide.